MDS disease characteristics, not donor source, predict hematopoietic stem cell transplant outcomes.

Bone Marrow Transplant · 2017 · PMC5382091 · PMID 27941767

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

did not reach statistical significanceP =0.07so close (0.05 < p ≤ 0.1)

There were lower rates of 2-year relapse with MA conditioning at 12% (95% CI, 0–24%) versus RIC+ATG at 32% (95% CI, 18–46%) versus RIC with no ATG at 42% (95% CI, 19–65%), but this did not reach statistical significance ( P =0.07).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.